Alcon Inc. (ALC)

Market Cap	47.59B
Revenue (ttm)	9.91B
Net Income (ttm)	1.02B
Shares Out	494.62M
EPS (ttm)	2.05
PE Ratio	46.75
Forward PE	29.47
Dividend	$0.34 (0.35%)
Ex-Dividend Date	May 13, 2025

Volume	1,212,455
Open	95.86
Previous Close	96.10
Day's Range	95.52 - 97.01
52-Week Range	79.63 - 101.10
Beta	0.77
Analysts	Buy
Price Target	106.22 (+10.78%)
Earnings Date	May 13, 2025

About ALC

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. It operates through two segments, Surgical and Vision Care. The company offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. Its cataract products include Centurion vision system, LenSx laser system, Verion reference unit and Verion digital marker, ...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1945
• Employees: 25,599
• Stock Exchange: NYSE
• Ticker Symbol: ALC
• Website: https://www.alcon.com

Financial Performance

In 2024, Alcon's revenue was $9.91 billion, an increase of 4.82% compared to the previous year's $9.46 billion. Earnings were $1.02 billion, an increase of 4.52%.

Analyst Forecast

According to 11 analysts, the average rating for ALC stock is "Buy." The 12-month stock price forecast is $106.22, which is an increase of 10.78% from the latest price.

Price Target

$106.22

(10.78% upside)

Analyst Consensus: Buy